Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Low Vitamin D Causes High Blood Pressure

By HospiMedica International staff writers
Posted on 26 Jun 2013
A new genetic study has confirmed that a causal association exists between low levels of vitamin D and hypertension.

Researchers at University College London (UCL; United Kingdom) conducted a Mendelian randomization analysis of 35 previous studies involving 150,846 individuals, using single nucleotide polymorphisms (SNPs) as proxy markers to reflect vitamin D levels. More...
The researchers examined associations of four vitamin D-related SNPs with 25 hydroxyvitamin D for validation, and with blood pressure for causal inference. All four SNPs were strongly associated with 25 hydroxyvitamin D, but none of the SNP-allele scores was associated with blood pressure or hypertension.

The results did confirm, however, earlier observational studies that showed a causal association between vitamin D levels and blood pressure, with every 10% increase in serum 25-hydroxyvitamin D concentrations associated with a 0.24 mmHg decrease in diastolic blood pressure, and an 8.1% decrease in the risk of developing hypertension. The study was presented at the European Society of Human Genetics, held during June 2013 in Paris (France).

“Our study strongly suggests that some cases of cardiovascular disease could be prevented through vitamin D supplements or food fortification,” said lead author and study presenter Vimal Karani Santhanakrishnan, PhD, of the Institute of Child Health at the UCL. “Our new data provide further support for the important nonskeletal effects of vitamin D.”

“Even with the likely presence of unobserved confounding factors, the approach we followed, known as Mendelian randomization, allows us to draw conclusions about causality because the genetic influence on disease is not affected by confounding,” added Dr. Santhanakrishnan. “To put it in simple terms, by using this approach we can determine the cause and effect and be pretty sure that we've come to the right conclusion on the subject.”

Related Links:

University College London



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.